Buchumschlag

Impact of disease-modifying therapies on evolving tissue damage in iron rim multiple sclerosis lesions: short report

We investigated the impact of disease-modifying therapies (DMTs) on the evolving tissue damage in iron rim multiple sclerosis lesions using a novel post-processing magnetic resonance imaging (MRI) approach, the T1/T2 ratio. In this study, on baseline and 1-year follow-up, T1/T2 ratios of iron rim le...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Eisele, Philipp (VerfasserIn) , Wittayer, Matthias Sebastian (VerfasserIn) , Weber, Claudia Ellen (VerfasserIn) , Platten, Michael (VerfasserIn) , Schirmer, Lucas (VerfasserIn) , Gass, Achim (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: December 2022
In: Multiple sclerosis journal
Year: 2022, Jahrgang: 28, Heft: 14, Pages: 2294-2298
ISSN:1477-0970
DOI:10.1177/13524585221106338
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1177/13524585221106338
Volltext
Verfasserangaben:Philipp Eisele, Matthias Wittayer, Claudia E Weber, Michael Platten, Lucas Schirmer and Achim Gass
Beschreibung
Zusammenfassung:We investigated the impact of disease-modifying therapies (DMTs) on the evolving tissue damage in iron rim multiple sclerosis lesions using a novel post-processing magnetic resonance imaging (MRI) approach, the T1/T2 ratio. In this study, on baseline and 1-year follow-up, T1/T2 ratios of iron rim lesions (IRLs) in patients starting DMT (dimethyl fumarate, fingolimod, ocrelizumab) did not statistically differ compared to patients without DMT. At the second follow-up, T1/T2 ratios were significantly lower in IRLs in patients without DMT (p = 0.002), suggesting that DMTs have a beneficial delayed effect on lesion evolution and tissue matrix damage in IRLs.
Beschreibung:Online veröffentlicht: 1. Juli 2022
Gesehen am 30.05.2023
Beschreibung:Online Resource
ISSN:1477-0970
DOI:10.1177/13524585221106338

Ähnliche Einträge